The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines)

Czech version

Authors: D. Fischerová; D. Cibula
Authors‘ workplace: Gynekologicko-porodnická klinika 1. LF UK a VFN, Praha, přednosta prof. MUDr. A. Martan, DrSc.
Published in: Ceska Gynekol 2019; 84(1): 40-48
Category:

Overview

Objective: In 2018 three European societies have joined to create clinically relevant guidelines on the diagnosis and management of cervical cancer. The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) agreed on diagnostic approaches in cervical cancer staging.

Design: Review article.

Setting: Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague.

Methods: A literature review of published data on cervical cancer staging.

Results: Physical examination with biopsy still has its place in histological confirmation of malignancy but doesn‘t offer much information on the extent of the disease. It is historically the first time when transvaginal/transrectal ultrasound (TVS/TRS) is recommended as an alternative to the magnetic resonance (MRI) in a primary workup. Both imaging modalities offer excellent soft tissue contrast resolution, which is crucial in tumour detection and evaluation of local extent of tumour, including the depth of tumour infiltration in the bladder and rectal wall. These new advances in imaging rendered the use of cystoscopy and rectoscopy redundant. Similarly, with the implementation of modern imaging in pretreatment staging, intravenous urography has lost its role in the staging.

Apart from the local extent of the disease, it is necessary to accurately evaluate the lymph node status in order to plan optimal treatment. The detection rate of imaging reflects the prevalence of lymph node metastases depending on tumor stage and size of metastasis. In the early stage disease (T1a, T1b1, T2a1) with negative lymph nodes on TVS/TRS or MRI, surgicopathological staging of pelvic lymph nodes is a method of choice for detection of small volume metastases. Both imaging modalities might not detect small metastatic lesions within non-enlarged lymph nodes, but by identifying the characteristic changes of the infiltrated lymph nodes they have very low rate of false positives.

In locally advanced cervical cancer (T1b2 and higher, except T2a1) or early stages with positive lymph nodes detected on ultrasound or MRI, computed tomography (CT) or CT in combination with positron emission tomography (PET-CT) are recommended to assess distant spread including paraaortic lymph nodes and chest. PET-CT is the preferred option in cases indicated for primary chemoradiation. Unfortunatelly no imaging method is accurate enough to exclude small volume metastasis in paraaortic nodes. In the cases with negative paraaortic lymph nodes on CT or PET-CT, surgicopathological staging with dissection of the paraaortic lymph nodes may be considered. In order to reduce false positive findings by imaging methods, it is recomended to obtain an ultrasound or CT-guided tru-cut biopsy from any equivocal extrauterine lesion to avoid inappropriate treatment.

Conclusion: This review offers scientific evidence that led to the recent changes in the cervical cancer staging.

Keywords:

ultrasound – cervix – magnetic resonance

Sources

1. Amendola, MA., Hricak, H., Mitchell, DG., et al. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. J Clin Oncol, 2005, 23, 30, p. 7454–7459.

2. Cibula, D., Potter, R., Planchamp, F., et al. The European Society of Gynaecological Oncology / European Society for Radiotherapy and Oncology / European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int J Gynecol Cancer, 2018, 28, 4, p. 641–655.

3. Epstein, E., Testa, A., Gaurilcikas, A., et al. Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound – an European multicenter trial. Gynecol Oncol, 2013, 128, 3, p. 449–453.

4. Fischerova, D. Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol, 2011, 38, 3, p. 2462–2466.

5. Fischerova, D., Cibula, D., Dundr, P., et al. Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors. Int J Gynecol Cancer, 2008, 18, 4, p. 833–837.

6. Fischerova, D., Cibula, D., Stenhova, H., et al. Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. Int J Gynecol Cancer, 2008, 18, 4, p. 766–772.

7. Gong, Y., Wang, Q., Dong, L., et al. Different imaging techniques for the detection of pelvic lymph nodes metastasis from gynecological malignancies: a systematic review and meta-analysis. Oncotarget, 2017, 8, 8, p. 14107–14125.

8. Hricak, H., Gatsonis, C., Chi, DS., et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651 – Gynecologic Oncology Group 183. J Clin Oncol, 2005, 23, 36, p. 9329–9337.

9. Huang, WC., Yang, JM., Yang, YC., Yang, SH. Ultrasonographic characteristics and cystoscopic correlates of bladder wall invasion by endophytic cervical cancer. Ultrasound Obstet Gynecol, 2006, 27, 6, p. 680–686.

10. Chiappa, V., Di Legge, A., Valentini, AL., et al. Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging with regard to parametrial infiltration in cervical cancer. Ultrasound Obstet Gynecol, 2014.

11. Choi, HJ., Ju, W., Myung, SK., Kim, Y. Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci, 2010, 101, 6, p. 1471–1479.

12. Iwamoto, K., Kigawa, J., Minagawa, Y., et al. Transvaginal ultrasonographic diagnosis of bladder-wall invasion in patients with cervical cancer. Obstet Gynecol, 1994, 83, 2, p. 217–219.

13. Kang, S., Kim, SK., Chung, DC., et al. Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis. J Nucl Med, 2010, 51, 3, p. 360–367.

14. Meva, J., Chaudhary, RK., Bhaduri, D., et al. Lacunae in International Federation of Gynecology and Obstetrics (FIGO) classification for cervical carcinoma: observational study using TNM classification as comparator. Int J Gynecol Cancer, 2013, 23, 6, p. 1071–1077.

15. Mitchell, DG., Snyder, B., Coakley, F., et al. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol, 2006, 24, 36, p. 5687–5694.

16. Quinn, MA., Benedet, JL., Odicino, F., et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 2006, 95, Suppl. 1, p. S43–103.

17. Rockall, AG., Ghosh, S., Alexander-Sefre, F., et al. Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA? Gynecol Oncol, 2006, 101, 2, p. 244–249.

18. Selman, TJ., Mann, C., Zamora, J., et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ, 2008, 178, 7, p. 855–862.

19. Shen, G., Zhou, H., Jia, Z., Deng, H. Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymphnodes in patients with cervical cancer: a systematic review and meta-analysis. Br J Radiol, 2015, 88, 1052, p. 20150063.

20. Testa, AC., Ludovisi, M., Manfredi, R., et al. Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. Ultrasound Obstet Gynecol, 2009, 34, 3, p. 335–344.

21. Thomeer, MG., Gerestein, C., Spronk, S., et al. Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis. Eur Radiol, 2013, 23, 7, p. 2005–2018.

22. Tsunoda, AT., Marnitz, S., Soares Nunes, J., et al. Incidence of Histologically Proven Pelvic and Para-Aortic Lymph Node Metastases and Rate of Upstaging in Patients with Locally Advanced Cervical Cancer: Results of a Prospective Randomized Trial. Oncology, 2017, 92, 4, p. 213–220.

23. Zikan, M., Fischerova, D., Pinkavova, I., et al. Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology. Ultrasound Obstet Gynecol, 2010, 36, 6, p. 767–772